Becker's Healthcare February 28, 2025
Alexandra Murphy

Amid growing concerns over rising prescription drug prices, lawmakers are ramping up efforts to scrutinize pharmacy benefit managers, Fox affiliate WBFF reported Feb. 26.

Here are four things to know:

  1. A House Energy and Commerce subcommittee held a hearing Feb. 26 to discuss potential legislative solutions aimed at reducing the PBM influence over drug costs.
  2. Three of the top PBMs — CVS Caremark, Cigna Express Scripts and UnitedHealth’s Optum Rx — control 80% of U.S. prescriptions, which has raised concerns about anti-competitive practices that could drive up...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
How 4 top pharmacy leaders are leveraging AI for transformation
Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator
Private equity deal would set stage for 3-way Walgreens split: Report
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M
The Current, Future Roles of AI within the Pharmacy Profession

Share This Article